 |
인쇄하기
취소
|
LG Life Sciences Wins Exclusive Marketing Right for AMEVIVE
LG Life Sciences, Ltd. and Biogen Idec Inc., a U.S.-based biotechnology company, have recently agreed to make LG Life Sciences an exclusive marketing partner for sale of Biogen’s AMEVIVE (Alefacept) in Korea.
AMEVIVE is the first biological medication approved by the U.S. FDA back in January of 2003, for the treatment of patients with moderate to severe chronic plaque psoriasis. While the e...
AMEVIVE is the first biological medication approved by the U.S. FDA back in January of 2003, for the treatment of patients with moderate to severe chronic plaque psoriasis. While the e...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.